RadNet Inc. (RDNT) EVP Norman R. Hames Sells 7,500 Shares
RadNet Inc. (NASDAQ:RDNT) EVP Norman R. Hames sold 7,500 shares of the stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $9.68, for a total transaction of $72,600.00. Following the completion of the transaction, the executive vice president now directly owns 397,587 shares of the company’s stock, valued at $3,848,642.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Shares of RadNet Inc. (NASDAQ:RDNT) traded up $0.05 during trading on Monday, reaching $9.70. 207,388 shares of the company’s stock were exchanged, compared to its average volume of 207,092. RadNet Inc. has a 12 month low of $5.25 and a 12 month high of $11.90. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $459.57, a PE ratio of 32.17, a PEG ratio of 3.24 and a beta of 0.82.
RadNet (NASDAQ:RDNT) last issued its earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.12. The company had revenue of $227.60 million during the quarter, compared to analysts’ expectations of $232.84 million. RadNet had a net margin of 1.21% and a return on equity of 23.73%. The firm’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period last year, the company posted $0.11 earnings per share. research analysts predict that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.
Hedge funds have recently added to or reduced their stakes in the company. Airain ltd acquired a new stake in shares of RadNet in the second quarter valued at approximately $100,000. National Planning Corp grew its position in shares of RadNet by 9.8% in the second quarter. National Planning Corp now owns 16,796 shares of the medical research company’s stock valued at $132,000 after purchasing an additional 1,500 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new stake in shares of RadNet in the third quarter valued at approximately $195,000. Prudential Financial Inc. grew its position in shares of RadNet by 15.2% in the second quarter. Prudential Financial Inc. now owns 20,410 shares of the medical research company’s stock valued at $158,000 after purchasing an additional 2,700 shares during the last quarter. Finally, Parallax Volatility Advisers L.P. grew its position in shares of RadNet by 122.0% in the second quarter. Parallax Volatility Advisers L.P. now owns 21,122 shares of the medical research company’s stock valued at $164,000 after purchasing an additional 117,148 shares during the last quarter. Institutional investors and hedge funds own 53.24% of the company’s stock.
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.